0001829126-22-014208.txt : 20220708
0001829126-22-014208.hdr.sgml : 20220708
20220708180019
ACCESSION NUMBER: 0001829126-22-014208
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220706
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Activist Investing LLC
CENTRAL INDEX KEY: 0001817604
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 221075468
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR.
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646 768 8417
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR.
CITY: NEW YORK
STATE: NY
ZIP: 10036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lazar David E.
CENTRAL INDEX KEY: 0001932843
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 221075469
MAIL ADDRESS:
STREET 1: VILLA 1, 14-43RD STREET
STREET 2: JUMEIRAH 2
CITY: DUBAI
STATE: C0
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
ownership.xml
3
X0206
3
2022-07-06
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001932843
Lazar David E.
VILLA 1, 14-43RD STREET
JUMEIRAH 2
DUBAI
C0
00000
UNITED ARAB EMIRATES
0
0
1
0
0001817604
Activist Investing LLC
1185 AVENUE OF THE AMERICAS, 3RD FLOOR.
NEW YORK
NY
10036
0
0
0
1
Member of 10% owner group
Common Stock, par value $0.001
1421133
D
Common Stock, par value $0.001
43145
I
By Activist Investing LLC
This Form 3 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
Securities of Titan Pharmaceuticals, Inc. (the "Issuer") beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.
Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ David E. Lazar
2022-07-08
Activist Investing LLC, By: /s/ David E. Lazar, Chief Executive Officer
2022-07-08